Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B

doi:10.3748/wjg.v19.i5.721

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5247)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

492

HTML

2739

Figures (1-2)

124

Tables (1-3)

129

Sum=3484

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1023

Download

740

Sum=1763

Feb 7, 2013 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 7, 2013; 19(5): 721-726
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.721

Full Size Figure Download Figure

Figure 2 Predictors of complete virological suppression. A: Hepatitis B e antigen status; B: Baseline hepatitis B virus DNA. CVS: Complete virological suppression.

Citation: Fahrtash-Bahin F, Kariyawasam VC, Gray T, Byth K, George J, Douglas MW. Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B. World J Gastroenterol 2013; 19(5): 721-726
URL: https://www.wjgnet.com/1007-9327/full/v19/i5/721.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i5.721